We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

RecipharmCobra Biologics Announces Successful Pre-Clinical TB Vaccine Results using its Oral Vaccine Delivery Platform (ORT-VAC™)

News   Jan 13, 2011

 
RecipharmCobra Biologics Announces Successful Pre-Clinical TB Vaccine Results using its Oral Vaccine Delivery Platform (ORT-VAC™)
 
 
 

RELATED ARTICLES

Human Blood-Brain Barrier Chip Aids Development of Brain-targeting Drugs

News

A microfluidic organ chip model of the human blood-brain barrier, that recapitulates in vivo barrier functions, offers a new preclinical tool for development of brain-targeting therapeutics.

READ MORE

A Faster Way to Create Complex Molecules

News

Synthetic biologists look to re-engineer cells to make complex molecules for specific needs, including pharmaceuticals. But the trial-and-error process is difficult and time-consuming. Now, by combining two state-of-the-art research approaches, researchers have created a fast, efficient way to engineer and analyze metabolic pathways.

READ MORE

Researchers Examine the Potential Misuse of Anti-anxiety Medication

News

There is concern about the misuse of the sedative anti-anxiety medication alprazolam because of the “high” it can create. A study found that non-medical use of alprazolam in the United Kingdom is a significant issue,

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE